YNR068C Antibody is a rabbit polyclonal antibody that specifically recognizes the uncharacterized YNR068C protein in Saccharomyces cerevisiae (Baker's yeast), particularly in strain 204508/S288c. The antibody targets a protein with a molecular weight of approximately 31,219 Da and is generated using recombinant Saccharomyces cerevisiae as the immunogen. The antibody undergoes antigen-affinity purification to ensure specificity and is designated for research use only, not for diagnostic procedures .
When designing experiments with this antibody, it's important to consider that as a polyclonal antibody, it likely recognizes multiple epitopes on the target protein, which may provide stronger signal detection but could potentially introduce cross-reactivity concerns that need validation. The recombinant nature of the immunogen suggests the antibody may preferentially recognize properly folded protein conformations.
The YNR068C Antibody is supplied in liquid format with a specific formulation that includes 0.03% Proclin 300 as a preservative, 50% glycerol, and 0.01M PBS at pH 7.4 . This formulation is designed to maintain antibody stability and activity during storage and handling procedures.
For optimal performance, the antibody should be stored at -20°C for long-term stability, with aliquoting recommended upon receipt to minimize freeze-thaw cycles that can compromise antibody function. When preparing to use the antibody, it should be thawed completely and equilibrated to room temperature, then mixed gently by tube inversion rather than vortexing, which can damage the antibody structure. Working dilutions should be prepared fresh for each experiment and should not be stored for extended periods.
A comprehensive validation strategy for YNR068C Antibody should include multiple complementary approaches:
Western blot analysis comparing wild-type yeast with a YNR068C knockout strain to confirm antibody specificity
Immunoprecipitation followed by mass spectrometry to identify all proteins recognized by the antibody
Competitive blocking experiments using recombinant YNR068C protein to demonstrate specific binding
Cross-strain validation to assess recognition consistency across different S. cerevisiae strains
Epitope mapping to characterize binding regions, particularly if protein domains have specific functions
Each validation step should be meticulously documented with detailed experimental conditions. For Western blot validation, protein samples should be prepared using standardized extraction methods, with equal loading confirmed by total protein staining rather than relying solely on housekeeping proteins that may vary across conditions.
Optimizing immunoprecipitation (IP) with YNR068C Antibody requires systematic modification of multiple parameters to achieve maximum specificity and yield:
Recommended IP Protocol Framework:
Cell lysis optimization:
Test multiple lysis methods (mechanical disruption with glass beads vs. enzymatic spheroplasting)
Compare buffer compositions varying in:
Salt concentration (150-400 mM NaCl)
Detergent type and concentration (0.5-1% NP-40, 0.1-0.5% Triton X-100)
pH range (7.0-8.0)
Always include fresh protease and phosphatase inhibitor cocktails
Antibody binding parameters:
Optimize antibody concentration (2-10 μg per 500 μg total protein)
Test incubation time (2 hours vs. overnight at 4°C)
Compare direct addition vs. pre-binding to beads
Washing stringency balance:
Develop a washing strategy that removes non-specific interactions while preserving specific binding
Test increasing salt concentrations (150-500 mM NaCl)
Evaluate detergent concentration effect (0.1-1%)
Compare number of washes (3-6 washes)
For each optimization step, analyze results by Western blotting for both the target protein and potential contaminants, documenting all parameters systematically for reproducibility.
For reliable quantification of YNR068C protein, researchers should consider these methodological approaches:
Western Blot Quantification Protocol:
Standard curve development:
Prepare a dilution series (5-7 points) of recombinant YNR068C protein
Load alongside experimental samples
Process all samples identically for antibody incubation and detection
Generate calibration curve of signal intensity vs. protein amount
Sample preparation controls:
Extract proteins using denaturing conditions (SDS extraction)
Quantify total protein using bicinchoninic acid (BCA) or Bradford assay
Load equal protein amounts (20-40 μg per lane)
Include technical replicates for statistical validation
Detection system considerations:
Use digital imaging systems rather than film for wider linear range
Avoid saturated signals which prevent accurate quantification
Apply background subtraction consistently across all samples
Normalization approach:
Use total protein normalization via stain-free technology or Ponceau staining
If using loading controls, validate their stability under your experimental conditions
Calculate target/reference ratio for each sample
For each quantification experiment, document exposure settings, image acquisition parameters, and quantification boundaries to ensure reproducibility across experiments.
Successful immunofluorescence with YNR068C Antibody in yeast requires optimizing multiple steps:
Yeast Immunofluorescence Protocol Framework:
Cell wall permeabilization strategies:
Test enzymatic digestion with zymolyase (0.1-1 mg/ml, 30-60 minutes)
Compare with DTT pretreatment followed by mild detergent permeabilization
Evaluate effect of fixative type on antibody accessibility (formaldehyde vs. methanol)
Fixation optimization:
Compare 4% paraformaldehyde (10-30 minutes) vs. methanol fixation (-20°C, 6-10 minutes)
Assess impact of fixation time on epitope preservation
Consider post-fixation quenching with glycine or sodium borohydride to reduce autofluorescence
Blocking and antibody incubation:
Test blocking solutions (3-5% BSA, 5-10% normal serum)
Optimize primary antibody dilution (starting range: 1:100-1:500)
Compare incubation times (1 hour at room temperature vs. overnight at 4°C)
Select appropriate secondary antibody with minimal cross-reactivity to yeast proteins
Controls for specificity:
YNR068C knockout strain as negative control
GFP-tagged YNR068C strain for colocalization validation
Secondary antibody-only samples to assess background
Systematic documentation of each parameter is essential for reproducibility across experiments and different yeast strains.
For discovering YNR068C protein interaction partners, implement this systematic co-immunoprecipitation approach:
Co-IP Optimization Strategy:
Buffer composition tailoring:
Test mild non-ionic detergents (0.1-0.5% NP-40 or Triton X-100)
Optimize salt concentration to preserve interactions (100-200 mM NaCl)
Include stabilizing agents (5-10% glycerol) to maintain complex integrity
Add reversible cross-linkers for transient interactions (DSP, 0.5-2 mM)
Experimental controls implementation:
"Bead-only" control to identify non-specific binders
IgG isotype control to account for antibody-related background
YNR068C knockout strain as negative control
Reciprocal Co-IP with antibodies against suspected partners
Sample preparation technique:
Gentle cell lysis to preserve protein complexes
Pre-clearing lysate with beads to reduce background
Stepwise washing gradient to identify stable vs. transient interactors
Native elution vs. denaturing elution comparison
Interaction validation approach:
Mass spectrometry identification of co-precipitating proteins
Filtering against CRAPome database to remove common contaminants
Confirmation by reciprocal Co-IP for selected candidates
Secondary validation by proximity labeling or yeast two-hybrid
Document interaction strength through quantitative analysis of pull-down efficiency, comparing protein abundance in input vs. immunoprecipitated fractions.
Adapting YNR068C Antibody for chromatin immunoprecipitation requires specific methodological considerations:
ChIP Protocol Optimization Framework:
Cross-linking parametrization:
Test formaldehyde concentration range (0.5-3%)
Optimize cross-linking time (10-30 minutes)
Consider dual cross-linking with disuccinimidyl glutarate (DSG) for improved efficiency
Verify cross-linking efficiency by examining protein-DNA complexes on SDS-PAGE
Chromatin fragmentation strategy:
Optimize sonication parameters specifically for yeast cells
Target fragment size of 200-500 bp for high resolution
Verify fragmentation by agarose gel electrophoresis
Consider enzymatic fragmentation alternatives (MNase digestion)
Antibody validation for ChIP:
Test antibody specificity under ChIP conditions
Compare enrichment between wild-type and YNR068C knockout strains
Determine optimal antibody amount (2-5 μg per reaction)
Include mock IP controls (no antibody, isotype control)
Data analysis considerations:
Normalize to input DNA for each primer set
Include non-target genomic regions as negative controls
Apply appropriate statistical analysis for replicate experiments
For ChIP-seq, implement peak calling with suitable algorithms for yeast genome
This systematic approach enables reliable identification of YNR068C chromatin interactions while minimizing false positives from non-specific binding.
When encountering non-specific binding with YNR068C Antibody, implement this systematic troubleshooting framework:
Western Blot Non-Specific Binding Troubleshooting:
| Parameter | Standard Condition | Modification 1 | Modification 2 | Modification 3 |
|---|---|---|---|---|
| Blocking | 5% milk in TBST, 1h RT | 5% BSA in TBST, 1h RT | Commercial blocker, 1h RT | 5% milk, overnight 4°C |
| Antibody dilution | 1:1000 in TBST | 1:2000 in TBST | 1:1000 in TBST + 0.1% SDS | 1:1000 in 5% milk |
| Wash stringency | 3x5 min TBST | 5x5 min TBST | 3x10 min TBST | 3x5 min high-salt TBST |
| Sample amount | 50 μg protein | 25 μg protein | 10 μg protein | 5 μg protein |
Immunoprecipitation Non-Specific Binding Remediation:
Pre-clear lysates thoroughly:
Extend pre-clearing time with Protein A/G beads (1-2 hours)
Add non-immune serum from the same species as the antibody
Use higher bead volume for pre-clearing (50-100 μl per ml lysate)
Optimize washing conditions:
Implement stepped washing with increasing salt concentration
Add low concentrations of competing detergents (0.1-0.5% SDS)
Increase wash volume and number of washes
Consider wash additives like 1-5% Triton X-100 to reduce hydrophobic interactions
Bead selection optimization:
Compare different bead types (agarose vs. magnetic)
Test various Protein A/G formulations based on antibody subclass
Consider covalent antibody coupling to eliminate antibody bands
Implement changes systematically, testing one modification at a time while keeping all other variables constant, and document outcomes comprehensively.
For investigating YNR068C dynamics throughout the cell cycle, implement this comprehensive methodological approach:
Cell Cycle Analysis Protocol:
Synchronization method selection:
Compare α-factor arrest (G1 phase), hydroxyurea block (S phase), and nocodazole treatment (G2/M phase)
Validate synchronization by flow cytometry with propidium iodide staining
Assess synchronization impact on YNR068C expression independently of cell cycle effects
Time-course experimental design:
Collect samples at precise intervals following release from synchronization
Process all samples identically for protein extraction and analysis
Quantify YNR068C levels alongside established cell cycle markers (Clb2, Sic1)
Document cell cycle progression via budding index and DNA content analysis
Microscopy-based approach:
Perform immunofluorescence at defined cell cycle points
Co-stain with DAPI for DNA visualization
Categorize cells based on morphology and nuclear positioning
Apply quantitative image analysis for protein abundance and localization
Data analysis framework:
Plot YNR068C levels against time post-release
Normalize to cell-cycle independent proteins
Apply appropriate statistical tests for cyclic data
Create comprehensive visualization showing protein dynamics across all cell cycle phases
This systematic approach enables distinction between genuine cell-cycle regulation and artifacts of synchronization methods.
To effectively examine YNR068C localization dynamics under stress, implement this methodological framework:
Stress Response Protocol Design:
Stress condition standardization:
Define precise stress parameters (temperature, duration, concentration)
Apply consistent stress application methods across experiments
Include recovery time points to assess reversibility
Validate stress responses using known markers (e.g., Msn2/4 nuclear translocation)
Microscopy approach adaptation:
Utilize live-cell imaging when possible to track dynamic changes
Implement rapid fixation methods to capture transient states
Consider photobleaching techniques to distinguish new synthesis from redistribution
Employ consistent exposure parameters for quantitative comparisons
Co-localization analysis:
Include markers for specific compartments (nucleus, ER, Golgi, vacuole, mitochondria)
Apply appropriate co-localization statistics (Pearson's, Manders' coefficients)
Use structured illumination or confocal microscopy for improved resolution
Develop clear criteria for scoring localization patterns
Quantification strategy:
Measure intensity ratios between compartments
Track protein redistribution kinetics
Analyze changes in aggregate/puncta formation
Apply automated image analysis for unbiased assessment
This approach enables reliable detection of conditional localization changes while distinguishing specific responses from general cellular disruption.
For robust statistical analysis of YNR068C Antibody-generated data, implement these methodological approaches:
Statistical Framework Based on Experiment Type:
Western blot quantification:
Verify normal distribution of data (Shapiro-Wilk test)
For normally distributed data: paired t-test (two conditions) or one-way ANOVA with post-hoc tests (multiple conditions)
For non-normally distributed data: Wilcoxon signed-rank test or Kruskal-Wallis with post-hoc tests
Report effect sizes along with p-values
Present data with individual points, mean/median, and appropriate error bars
Immunofluorescence intensity analysis:
Account for cellular heterogeneity through adequate sample size (>50 cells per condition)
Consider hierarchical statistical approaches (cells nested within experiments)
Apply appropriate transformations for non-normally distributed intensity data
Control for multiple comparisons with Bonferroni or Benjamini-Hochberg corrections
Colocalization analysis:
Select appropriate coefficients (Pearson's for linear relationships, Manders' for overlap)
Apply Fisher's z-transformation for comparing correlation coefficients
Utilize randomization tests to establish significance thresholds
Consider object-based approaches for punctate distributions
Time-course experiments:
Apply repeated measures ANOVA for continuous measurements
Consider time series analysis for cyclic patterns
Use area under curve calculations for cumulative effects
Implement mixed models to account for missing data points
For all statistical approaches, document software packages, statistical tests, significance thresholds, and any data transformations applied.
When facing discrepancies between different methods of YNR068C detection, implement this systematic reconciliation approach:
Methodological Reconciliation Framework:
Technical validation analysis:
Verify antibody performance in each method separately
Confirm positive and negative controls work appropriately in each system
Assess whether detection sensitivity differs between methods
Examine whether sample preparation might affect epitope accessibility
Biological interpretation considerations:
Evaluate if discrepancies reflect different protein pools or conformations
Consider post-translational modifications that might affect antibody recognition
Assess potential for protein complex formation masking epitopes
Examine if cellular compartmentalization might explain differences
Reconciliation experimental design:
Implement orthogonal detection methods (e.g., epitope tagging)
Use multiple antibodies targeting different epitopes
Apply genetic approaches (knockout/knockdown) for validation
Design experiments specifically addressing the source of discrepancy
Documentation and reporting:
Clearly describe discrepancies rather than selectively reporting concordant results
Present side-by-side comparisons with standardized samples
Discuss limitations of each method objectively
Propose biological or technical explanations for differences
This systematic approach transforms apparent contradictions into deeper insights about YNR068C biology and methodological limitations.
YNR068C Antibody can be leveraged with cutting-edge technologies to achieve deeper protein characterization:
Advanced Technology Integration Strategies:
Proximity labeling applications:
Combine with BioID or APEX2 systems to map protein interaction networks
Identify transient interactions that traditional co-IP might miss
Characterize spatial organization of YNR068C in specific cellular compartments
Compare interaction profiles under different physiological conditions
Single-cell analysis approaches:
Adapt for mass cytometry (CyTOF) with metal-conjugated antibodies
Implement in microfluidic platforms for studying cell-to-cell variability
Combine with single-cell transcriptomics for multi-omics correlation
Develop flow cytometry protocols for measuring YNR068C in individual yeast cells
Advanced microscopy integration:
Optimize for super-resolution techniques (STORM, PALM, STED)
Implement live-cell nanobody derivatives for dynamic studies
Apply correlative light and electron microscopy (CLEM) for ultrastructural context
Utilize lattice light-sheet microscopy for 3D dynamics with reduced phototoxicity
Computational biology approaches:
Integrate antibody-derived localization data with protein structure predictions
Apply machine learning for pattern recognition in complex YNR068C datasets
Develop systems biology models incorporating YNR068C function
Create predictive models of protein behavior under various conditions
These integration strategies position YNR068C research at the cutting edge of yeast molecular biology while maximizing the utility of existing antibody resources.